Paradox Immunotherapeutics

Developer of immunotherapeutics for the treatment of rare diseases

placeToronto, Ontario, Canada calendar_todayFounded 2019 groups9 employees language paradoximmuno.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace steady. Cited 2 times.

YearFilings
20231
20251

Social engagement

Social engagement: 2K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital267%
Accelerator & incubator133%

Recent activity

18 May 2026
Event
PEGSummit Boston
Coming soon